Pages that link to "Q73782033"

The following pages link to Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: A meta-analysis of diagnostic test characteristics (Q73782033):

Displaying 16 items.

• Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies (Q22305832) (← links)
• Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C. (Q30444892) (← links)
• Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients. (Q34876460) (← links)
• Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C (Q35800747) (← links)
• Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial (Q36933129) (← links)
• Cost-effectiveness of treatments for chronic hepatitis C. (Q40780468) (← links)
• Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials. (Q41729153) (← links)
• Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines. (Q42988157) (← links)
• Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. (Q43032576) (← links)
• Sampling Variability on Percutaneous Liver Biopsy in Patients with Chronic Hepatitis C Virus Infection (Q45723659) (← links)
• Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C. (Q47712978) (← links)
• Sustained viral response to pegylated interferon alpha-2b and ribavirin in chronic hepatitis C refractory to prior treatment (Q50575290) (← links)
• Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C. (Q50586994) (← links)
• Antiviral treatment of hepatitis C virus infection (Q50587454) (← links)
• Predictors of sustained response to alpha interferon therapy in chronic hepatitis C (Q73310296) (← links)
• Changes in histological lesions and serum fibrogenesis markers in chronic hepatitis C patients non-responders to interferon alpha (Q74336131) (← links)